Evidence map›Paper›PMID 15728923›Full record

ArticleAntimicrobial agents and chemotherapy2005

A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis.

Xiao-Qing Qiu, Jie Zhang, He Wang, George Y Wu

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Control ofMicrobiology spectrum · 2023
    Article
  2. Article
  3. [Materials for Selective Inhibition ofSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Selective activities of STAMPs againstExperimental and therapeutic medicine · 2018
    Article
  8. Article
  9. Pro-moieties of antimicrobial peptide prodrugs.Molecules (Basel, Switzerland) · 2015
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiao-Qing QiuLaboratory of Biomembrane and Membrane Protein, West China Hospital, Chengdu, People's Republic of China.
Jie Zhang
He Wang
George Y Wu

Funding

TARGETED GENE DELIVERY &EXPRESSION IN HEPATOCYTESR01DK042182 · NIDDK · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI WU, GEORGE Y · 1990 to 2005
$1.6M
NIDDK NIH HHS R01 DK042182
6 · The paper itself

Abstract

A novel antienterococcal peptide was prepared by fusing the enterococcal cCF10 pheromone to the channel-forming domain of colicin Ia, forming Enterococcus faecalis pheromonicin (PMC-EF). This peptide was bactericidal against vancomycin-resistant Enterococcus faecalis (VRE) organisms. Electron microscopy and vital dyes confirmed increased membrane permeability. All mice made bacteremic with VRE strains survived when they were treated with PMC-EF, while all controls died.

Indexed as

PeptidesVancomycin ResistanceAnti-Bacterial AgentsBase SequenceColicinsEnterococcus faecalisMicrobial Sensitivity TestsMolecular Sequence DataProtein EngineeringAnti-Bacterial AgentsColicinsPeptides

Identifiers

PMID15728923
PMCPMC549282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.